Peter T Lansbury

USPTO Granted Patents = 23 (Patent Applications = 17)

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 20)

Average Co-Inventor Count = 3.9

ph-index = 10

Forward Citations = 288(Granted Patents)

Company Filing History:

10 out of 10

Bial - R&d Investments, S.a.

patents

7 out of 7

Lysosomal Therapeutics Inc.

patents

3 out of 3

Bial-biotech Investments, Inc.

patents

4. 2 out of 8,369

Massachusetts Institute of Technology

Link Medicine Corporation

patents

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12116369 - Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators (2024-10-15),

2. 11932645 - Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2024-03-19),

3. 11878979 - Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders (2024-01-23),

4. 11453675 - Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2022-09-27),

5. 11400095 - Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2022-08-02),

6. 11351173 - Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders (2022-06-07),

7. 11345698 - Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders (2022-05-31),

8. 11192892 - Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders (2021-12-07),

9. 11168087 - Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders (2021-11-09),

10. 11124516 - Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2021-09-21),

11. 11091492 - Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2021-08-17),

12. 10934298 - Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders (2021-03-02),

13. 10787454 - Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2020-09-29),

14. 10786508 - Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders (2020-09-29),

15. 10751341 - Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders (2020-08-25),

Title: Innovations of Peter T Lansbury: A Leader in Medical Chemistry

Introduction

Peter T Lansbury is a prominent inventor based in Brookline, MA, known for his significant contributions to the field of medical chemistry. With an impressive portfolio of 23 patents, his work focuses primarily on developing innovative therapeutic compounds for treating serious medical disorders.

Latest Patents

Among Lansbury's latest patents are his inventions regarding substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators. These inventions include substituted pyrazolo[1,5-a]pyrimidinyl carboxamide and related organic compounds. They are designed to treat various medical disorders such as Gaucher disease, Parkinson's disease, Lewy body disease, dementia, and multiple system atrophy. One exemplary compound mentioned in his patents is 2-heterocyclyl-4-alkyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Similarly, his inventions related to substituted pyrazolo[1,5-a]pyrimidines detail methods for using these compounds, compositions, and medical kits for the effective treatment of the aforementioned disorders. One notable compound described is 5,7-dimethyl-N-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide.

Career Highlights

Lansbury has made significant strides in the pharmaceutical industry, contributing to the advancement of medical treatments through his patents. He has worked with reputable companies such as Bial–r&d Investments, S.a. and Lysosomal Therapeutics Inc., where he has been instrumental in driving innovation and research. His commitment to developing effective therapies showcases his importance in the medical research community.

Collaborations

Throughout his illustrious career, Lansbury has collaborated with fellow researchers and inventors, including Renato T Skerlj and Elyse Marie Josee Bourque. These partnerships have enabled him to work on groundbreaking projects and enrich the scientific community with innovative solutions.

Conclusion

Peter T Lansbury's extensive patent portfolio and his dedication to advancing medical chemistry highlight his role as an influential inventor. His latest work in developing compounds for serious medical disorders has the potential to significantly impact patient care and treatment outcomes. As he continues to develop innovative solutions, Lansbury remains a key figure in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.